Martin Farlow

Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

Susan Landau, Andy Horng, Allison Fero et al. · Neurology · 2016 · 125 citations · Full text

Medicine, Neurology, Neuroscience +17

Hexanucleotide repeat expansions in <i>C9ORF72</i> in the spectrum of motor neuron diseases

Wouter van Rheenen, Marka van Blitterswijk, Mark Huisman et al. · Neurology · 2012 · 119 citations · Full text

Life Sciences, Molecular Genetics, Neurology +17

Polygenic risk scores in familial Alzheimer disease

Giuseppe Tosto, Thomas D. Bird, Debby W. Tsuang et al. · Neurology · 2017 · 71 citations · Full text

Life Sciences, Genetics, Neurology +17

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease

Pontus Erickson, Joel Simrén, Wagner S. Brum et al. · JAMA Neurology · 2023 · 46 citations · Full text

Medicine, Neurology, Neuroscience +17

Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

Julie K. Wisch, Nicole S. McKay, Anna H. Boerwinkle et al. · The Lancet Neurology · 2024 · 36 citations · Full text

Life Sciences, Neurology, Neuroscience +16